Delineation of A 2.8 Megabases Region Harboring A Potential Tumor Suppressor Gene Involved in Renal Cell Carcinoma, That Is Commonly Deleted from Chromosome 14

Anticancer Research

Volumn 23, Issue 6 C, 2003, Pages 4865-4870

  Gallou, Catherine ^a,b   Méjean, Arnaud ^a,b   Bouvier, Raymonde ^c   Lucien, Florence ^a   Perennou, Morgan ^a   Zindy, Pierre Joachim ^a   Grifone, Raphaelle ^a   Chrétien, Yves ^b   Junien, Claudine ^a   Béroud, Christophe ^a  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Chromosome 14; Loss of heterozygosity; Renal cell carcinoma; Tumor suppressor gene

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMOSOME 14; CHROMOSOME 14Q; FEMALE; GENE DELETION; GENE FUNCTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, RENAL CELL; CHROMOSOMES, HUMAN, PAIR 14; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED;

EID: 10744225401     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 49: 8-31, 1, 1999.
2. Godley PA and Escobar MA: Renal cell carcinoma. Curr Opin Oncol 10: 261-5, 1998.
3. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B and Iczkowski K: Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80: 987-9, 1997.
4. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Storkel S, van den Berg E and Zbar B: The Heidelberg classification of renal cell tumours. J Pathol 183: 131-3, 1997.
5. Fournet JC, Beroud C, Austruy E and Leonard C: Aspects génétiques des tumeurs rénales de l'adulte. Arch Anat Cytol Pathol 40: 301-6, 1992.
6. Thrash-Bingham CA, Greenberg RE, Howard S, Bruzel A, Bremer M, Goll A, Salazar H, Freed JJ and Tartof KD: Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes. Proc Natl Acad Sci USA 92: 2854-8, 1995.
7. Béroud C, Fournet JC, Jeanpierre C, Droz D, Bouvier R, Froger D, Chretien Y, Marechal JM, Weissenbach J and Junien C: Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas. Genes Chromosomes Cancer 17: 215-24, 1996.
8. Moch H, Presti JC, Jr., Sauter G, Buchholz N, Jordan P, Mihatsch MJ and Waldman FM: Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 56: 27-30, 1996.
9. Herbers J, Schullerus D, Muller H, Kenck C, Chudek J, Weimer J, Bugert P and Kovacs G: Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Genes Chromosomes Cancer 19: 29-35, 1997.
10. Schullerus D, Herbers J, Chudek J, Kanamaru H and Kovacs G: Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas. J Pathol 183: 151-5, 1997.
11. Wu SQ, Hafez GR, Xing W, Newton M, Chen XR and Messing E: The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma. Cancer 77: 1154-60, 1996.
12. Zambrano NR, Lubensky IA, Merino MJ, Linehan WM and Walther MM: Histopathology and molecular genetics of renal tumors toward unification of a classification system. J Urol 162: 1246-58, 1999.
13. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260: 1317-20, 1993.
14. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJ, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Zbar B et al: Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16: 68-73, 1997.
15. Kovacs G and Frisch S: Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res 49: 651-9, 1989.
16. Mitsumori K, Kittleson JM, Itoh N, Delahunt B, Heathcott RW, Stewart JH, McCredie MR and Reeve AE: Chromosome 14q LOH in localized clear cell renal cell carcinoma. J Pathol 198: 110-4, 2002.
17. Presti JC, Jr., Wilhelm M, Reuter V, Russo P, Motzer R and Waldman F: Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney. J Urol 167: 1464-8, 2002.
18. Polascik TJ, Cairns P, Epstein JI, Fuzesi L, Ro JY, Marshall FF, Sidransky D and Schoenberg M: Distal nephron renal tumors: microsatellite allelotype. Cancer Res 56: 1892-5, 1996.
19. Herbers J, Schullerus D, Chudek J, Bugert P, Kanamaru H, Zeisler J, Ljungberg B, Akhtar M and Kovacs G: Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas. J Pathol 184: 58-62, 1998.
20. Wylie AA, Murphy SK, Orton TC and Jirtle RL: Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation. Genome Res 10: 1711-8, 2000.
21. Martinez-Delgado B, Melendez B, Cuadros M, Jose Garcia M, Nomdedeu J, Rivas C, Fernandez-Piqueras J and Benitez J: Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas. Int J Cancer 102: 15-9, 2002.
22. Ahomadegbe JC, Tourpin S, Kaghad M, Zelek L, Vayssade M, Mathieu MC, Rochard F, Spielmann M, Tursz T, Caput D, Riou G and Benard J: Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers. Oncogene 19: 5413-8, 2000.
23. Menon AG, Rutter JL, von Sattel JP, Synder H, Murdoch C, Blumenfeld A, Martuza RL, von Deimling A, Gusella JF and Houseal TW: Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus. Oncogene 14: 611-6, 1997.
24. De Rienzo A, Jhanwar SC and Testa JR: Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma. Genes Chromosomes Cancer 28: 337-341, 2000.